PubMed Health⌕ Search

PubMed · 17061470

["Ready to use" medications. A guide to limit errors when using medications].

Abstract

Errors in the use of medicines are preventable incidents which may occur at any point in a chain beginning with prescription and continuing on through dispensation and administration of medicine; these errors have multi-factorial causes. Those which are potentially the most dangerous take place in hospital environment and some of them directly affect nursing personnel since they occur during the process when medicines are prepared and administered via an intravenous drip or injection. Pre-diluted medicines for intravenous use, known as "ready to use" preparations, help to reduce the amount of errors associated with the preparation and administration of medicines. These preparations guarantee the correct prescribed dose and eliminate errors related to an incorrectly labeled medicine. Moreover these ready to use medicines avoid a manipulation of the pharmaceutical product, limit the risk of particles being dragged, reduce nursing time employed in preparation of medicines substantially, and prevent accidental needle scratches during the preparation process.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Luis Salas Campos, Marta Fernández Mansilla, Vanesa Estudillo Pérez. 2006. ["Ready to use" medications. A guide to limit errors when using medications].. https://pubmed.ncbi.nlm.nih.gov/17061470/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Extending basic principles of measurement models to the design and validation of Patient Reported Outcomes.

A recently published article by the Scientific Advisory Committee of the Medical Outcomes Trust presents guidelines for selecting and evaluating health status and health-related quality of life measures used in health outcomes research. In their article, they propose a number of validation and performance criteria with which to evaluate such self-report measures. We provide an alternate, yet complementary, perspective by extending the types of measurement models which are available to the instrument designer. During psychometric development or selection of a Patient Reported Outcome measure it is necessary to determine which, of the five types of measurement models, the measure is based on; 1) a Multiple Effect Indicator model, 2) a Multiple Cause Indicator model, 3) a Single Item Effect Indicator model, 4) a Single Item Cause Indicator model, or 5) a Mixed Multiple Indicator model. Specification of the measurement model has a major influence on decisions about item and scale design, the appropriate application of statistical validation methods, and the suitability of the resulting measure for a particular use in clinical and population-based outcomes research activities.

Guidelines as Topic↗

International guidance on the establishment of quality assurance programmes for radioactivity measurement in nuclear medicine.

A new guidance document for the implementation of quality assurance (QA) programmes for nuclear medicine radioactivity measurement, produced by the International Atomic Energy Agency, is described. The proposed programme is based on the principles of ISO 17025 and will enable laboratories, particularly in developing countries, to provide consistent, safe and effective radioactivity measurement services to the nuclear medicine community.

Guidelines as Topic↗

A cautionary tale.

Explore the source record for details and available documents.

Guidelines as Topic↗